3 completed, 1 active not recruiting, 1 not yet recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Matthieu Pelletier-Galarneau, MD MSc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Parathyroid Adenoma Detection With Rubidium-82 Imaging PET/CT imaging with rubidium-82 - Parathyroid Adenomas, Hyperparathyroidism, Primary | Not yet recruiting | Matthieu Pelletier-Galarneau, MD MSc | 20 | 2025-11-01 | 2025-08-22 | |
| In Vivo Quantitative Mapping of Mitochondrial Cardiac Membrane Potential in Heart Failure Positron Emission Tomography (PET) - Mitochondrial Function | Active not recruiting | Matthieu Pelletier-Galarneau, MD MSc | 30 | 2024-11-25 | 2025-07-25 | |
| Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging Fast + High-fat low-carbohydrate diet, Fast + Empagliflozin - Myocardial Suppression | Not applicable | Completed | Matthieu Pelletier-Galarneau, MD MSc | 16 | 2024-06-01 | 2025-09-29 |
| Assessment of Renal Microcirculation With Rubidium Positron Emission Tomography Renal Microcirculation With Rubidium Positron Emission Tomography | Completed | Matthieu Pelletier-Galarneau, MD MSc | 30 | 2023-07-04 | 2025-07-29 | |
| Effect of a Single Ultra-Processed Meal on Myocardial Endothelial Function Assessed With Positron Emission Tomography NOVA4 meal, NOVA1-3 meal - Myocardial Endothelial Function | Not applicable | Completed | Matthieu Pelletier-Galarneau, MD MSc | 15 | 2020-08-20 | 2024-04-08 |
Heart Failure (1) · Hyperparathyroidism, Primary (1) · Parathyroid Neoplasms (1)
Magnetic Resonance Spectroscopy (1) · Rubidium-82 (1) · empagliflozin (1)
Canada (5)
Matthieu Pelletier-Galarneau (1)